Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Preferred Shares Issued (2020 - 2023)

Viridian Therapeutics, Inc.\DE (VRDN) has 1 years of Preferred Shares Issued data on record, last reported at $76.2 million in Q4 2023.

  • For Q4 2023, Preferred Shares Issued changed N/A year-over-year to $76.2 million; the TTM value through Dec 2025 reached $76.2 million, changed 0.0%, while the annual FY2024 figure was $25.0 million, 67.19% down from the prior year.
  • Preferred Shares Issued reached $76.2 million in Q4 2023 per VRDN's latest filing.
  • Across five years, Preferred Shares Issued topped out at $76.2 million in Q4 2023 and bottomed at $76.2 million in Q4 2023.